Study to Evaluate the Safety of Repatha® in Pregnancy
NCT02906124 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4
Last updated 2020-12-22
Summary
To evaluate pregnancy and infant outcomes among females diagnosed with familial hypercholesterolaemia (FH), exposed to Repatha® during pregnancy. This includes follow-up of their infants to the age of 12 months
Conditions
- Hypercholesterolaemia
- Pregnancy
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
MD · Amgen
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-12
- Primary Completion
- 2020-11-06
- Completion
- 2020-11-06
Countries
- Australia
- Austria
- Belgium
- Czechia
- Denmark
- Greece
- Italy
- Netherlands
- Norway
- Slovakia
- Spain
- Sweden
- Switzerland
- United Kingdom
Study Locations
More Related Trials
-
Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
NCT06113237 ·Status: RECRUITING
-
PlacEntal Acute Atherosis RefLecting Subclinical Atherosclerosis
NCT05500989 ·Status: RECRUITING
-
rhuFVIIa in Post-partum Hemorrhage
NCT00370877 ·Status: COMPLETED ·Phase: PHASE4
-
A Low Glycemic Load Diet During Pregnancy in Overweight Women
NCT00364403 ·Status: COMPLETED ·Phase: NA
-
RPL: Interval to Live Birth and Adverse Perinatal Outcomes
NCT04360564 ·Status: UNKNOWN
-
The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations
NCT02855047 ·Status: COMPLETED
-
Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes Mellitus
NCT03570632 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
NCT00721591 ·Status: COMPLETED
-
Indonesia Pravastatin to Prevent Preeclampsia Study
NCT03648970 ·Status: UNKNOWN ·Phase: PHASE2
-
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
NCT05180773 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluation of the LMWH Thromboprophylaxis in Pregnancy
NCT01394107 ·Status: COMPLETED
-
Safety and Efficacy of RLX030 in Pregnant Women With Pre- Eclampsia
NCT01566630 ·Status: TERMINATED ·Phase: PHASE2
-
Lipid Profile as Predictor of Adverse Maternal and Neonatal Outcomes: A Pilot Study
NCT05535660 ·Status: COMPLETED
-
Pravastatin to Prevent Preeclampsia
NCT03944512 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Nicotinamide in Early Onset Preeclampsia
NCT03419364 ·Status: COMPLETED ·Phase: PHASE2
-
Non Invasive Prenatal Testing (NIPT) of Single-gene Disorders
NCT02339402 ·Status: UNKNOWN
-
Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy
NCT05419037 ·Status: RECRUITING
-
Losartan for Improved Vascular Endothelial Function After Preeclampsia
NCT04632589 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety of Direct Oral Anticoagulant During Pregnancy
NCT06179823 ·Status: COMPLETED
-
Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia
NCT05937841 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
TIPPS: Thrombophilia in Pregnancy Prophylaxis Study
NCT00967382 ·Status: COMPLETED ·Phase: PHASE3
-
Technical Feasibility of the cfDNA Test for Non-invasive Cytogenetic Analysis of Early Miscarriages Versus the Gold Standard Microarray
NCT05900076 ·Status: COMPLETED
-
Chronic Hypertension and Pregnancy (CHAP) Project
NCT02299414 ·Status: COMPLETED ·Phase: PHASE4
-
Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy
NCT00579150 ·Status: TERMINATED
-
The Cymbalta Pregnancy Registry
NCT01074151 ·Status: COMPLETED